Danbury, CT, United States of America

Jonathan Emilian Emeigh

This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2002-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Emilian Emeigh. Retrieved from https://idiyas.com/inventor/jonathan-emilian-emeigh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jonathan Emilian Emeigh

Introduction

Jonathan Emilian Emeigh is an accomplished inventor based in Danbury, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases. With a total of 2 patents, Emeigh's work is recognized for its potential impact on medical science.

Latest Patents

Emeigh's latest patents focus on small molecules that are useful in the treatment of inflammatory diseases. These innovations represent a crucial step forward in developing effective therapies for conditions that affect millions of people worldwide.

Career Highlights

Emeigh is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at this leading pharmaceutical company allows him to collaborate with other experts in the field and contribute to groundbreaking medical solutions.

Collaborations

Emeigh has worked alongside notable colleagues such as Jiang-Ping Wu and Terence Alfred Kelly. These collaborations have further enriched his research and have led to significant advancements in their shared field of study.

Conclusion

Jonathan Emilian Emeigh's contributions to the pharmaceutical industry highlight his dedication to innovation and improving healthcare outcomes. His work on small molecules for inflammatory diseases showcases the importance of research in developing new treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…